Cupric Chloride

CHEMBL444436 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

134.4 g/mol

LogP

—

Phase

4

An inorganic copper salt used as a trace element supplement in parenteral nutrition to prevent copper deficiency. Copper is essential for numerous enzymatic processes in the body including iron metabolism and connective tissue formation.

分子量

134.4500 g/mol

TPSA

0.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl[Cu]Cl

InChI

InChI=1S/2ClH.Cu/h2*1H;/q;;+2/p-2

Molecular Formula

Cl2Cu

HBD / HBA

- / -

回転可能結合数

0

重原子数

3

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

An inorganic copper salt used as a trace element supplement in parenteral nutrition to prevent copper deficiency. Copper is essential for numerous enzymatic processes in the body including iron metabolism and connective tissue formation.

Yes, Cupric Chloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL444436. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24014. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Cupric Chloride PillFYIで

構造

クイックデータ

分子式: Cl2Cu
同義語: 6

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.